Page 44 - Read Online

Page 10 of 10 Dumane et al. J Cancer Metastasis Treat 2019;5:42 I http://dx.doi.org/10.20517/2394-4722.2019.08

Conflicts of interest
All authors declared that there are no conflicts of interest.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2019.

REFERENCES
1. Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in
practice. Br J Rad 2011;84:967-96.
2. Mayo CS, Ding L, Addesa A, Kadish S, Fitzgerald TJ, Moser R. Initial experience with volumetric IMRT (RapidArc) for intracranial
stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010;78:1457-66.
3. Wolff HA, Wagner DM, Christiansen H, Hess CF, Vorwerk H. Single fraction radiosurgery using RapidArc for treatment of intracranial
targets. Radiat Oncol 2010;5:77.
4. Clark GM, Popple RA, Young PE, Fiveash JB. Feasibility of single-isocenter volumetric modulated arc radiosurgery for treatment of
multiple brain metastases. Int J Radiat Oncol Biol Phys 2010;76:296-302.
5. Liu H, Andrews DW, Evans JJ, Werner-Wasik M, Yu Y, et al. Plan quality and treatment efficiency for radiosurgery to multiple brain
metastases: non-coplanar rapidarc vs Gamma Knife. Front Oncol 2016;6:26.
6. Thomas EM, Popple RA, Wu X, Clark GM, Markert JM, et al. Comparison of plan quality and delivery time between volumetric
modulated arc therapy (RapidArc) and Gamma Knife radiosurgery for multiple cranial metastases. Neurosurgery 2014;75:409-17.
7. Clark GM, Popple RA, Prendergast BM, Spencer SA, Thomas EM, et al. Plan quality and treatment planning technique for single
isocenter cranial radiosurgery with volumetric modulated arc therapy. Pract Radiat Oncol 2012;2:306-13.
8. Ballangrud Å, Kuo LC, Happersett L, Lim SB, Beal K, et al. Institutional experience with SRS VMAT planning for multiple cranial
metastases. J Appl Clin Med Phys 2018;19:176-83.
9. Moore KL, Brame RS, Low DA, Mutic S. Experience-based quality control of clinical intensity-modulated radiotherapy planning. Int J
Radiat Oncol Biol Phys 2011;81:545-51.
10. Appenzoller L, Michalski J, Thorstatd W, Mutic S, Moore KL. Predicting dose-volume histograms for organs-at-risk in IMRT planning.
Med Phys 2012;39:7446-61.
11. Chanyavanich V, Das SK, Lee WR, Lo JY. Knowledge-based IMRT treatment planning for prostate cancer. Med Phys 2011;38:2515-22.
12. Wu B, Pang D, Simari P, Taylor R, Sanguineti G, McNutt T. Using overlap volume histogram and IMRT plan data to guide and automate
VMAT planning: A head-and-neck case study. Med Phys 2013;40:021714.
13. Fogliata A, Belosi F, Clivio A, Navarria P, Nicolini G, et al. On the pre-clinical validation of a commercial model-based optimization
engine: application to volumetric modulated arc therapy for patients with lung or prostate cancer. Radiother Oncol 2014;113:385-91.
14. Fogliata A, Wang PM, Belosi F, Clivio A, Nicolini G, et al. Assessment of a model based optimization engine for volumetric modulated
arc therapy for patients with advanced hepatocellular cancer. Radiother Oncol 2014;9:236-48.
15. Shiraishi S, Tan J, Olsen LA, Moore KL. Knowledge-based prediction of plan quality metrics in intracranial stereotactic radiosurgery.
Med Phys 2015;42:908-17.
16. Paddick I, Lippitz B. A simple dose gradient measurement tool to complement the conformity index. J Neurosurg 2006;105:194-201.
17. Yuan L, Ge Y, Lee WR, Yin FF, Kirkpatrick JP, et al. Quantitative analysis of the factors which affect the interpatient organ-at-risk dose
sparing variation in IMRT plans. Med Phys 2012;39:6868-78.
18. Minniti G, Clarke E, Lanzetta G, Osti MF, Trasimeni G, et al. Stereotactic radiosurgery for brain metastases: analysis of outcome and
risk of brain radionecrosis. Radiat Oncol 2011;6:48.
19. Blonigen BJ, Steinmetz RD, Levin L, Lamba MA, Warnick RE, et al. Irradiated volume as a predictor of brain radionecrosis after linear
accelerator stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2010;77:996-1001.